In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of UiPath Inc (NYSE: PATH) closed at $10.66 in the last session, down -2.47% from day before closing price of $10.93. In other words, the price has decreased by -$2.47 from its previous closing price. On the day, 9.05 million shares were traded. PATH stock price reached its highest trading level at $11.0 during the session, while it also had its lowest trading level at $10.575.
Ratios:
We take a closer look at PATH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.22. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 2.83. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Macquarie Downgraded its Outperform to Neutral on June 03, 2024, whereas the target price for the stock was revised from $29 to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 31 ’25 when Dines Daniel sold 9,988 shares for $12.00 per share. The transaction valued at 119,856 led to the insider holds 4,598,388 shares of the business.
Dines Daniel sold 45,000 shares of PATH for $542,776 on Jul 30 ’25. The CEO and Chairman now owns 4,608,376 shares after completing the transaction at $12.06 per share. On Jul 29 ’25, another insider, Dines Daniel, who serves as the CEO and Chairman of the company, sold 45,000 shares for $12.20 each. As a result, the insider received 548,788 and left with 4,653,376 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 5703515648 and an Enterprise Value of 4227433216. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.93 while its Price-to-Book (P/B) ratio in mrq is 3.36. Its current Enterprise Value per Revenue stands at 2.913 whereas that against EBITDA is -47.716.
Stock Price History:
The Beta on a monthly basis for PATH is 1.03, which has changed by -0.042228222 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $15.93, while it has fallen to a 52-week low of $9.38. The 50-Day Moving Average of the stock is -14.46%, while the 200-Day Moving Average is calculated to be -15.70%.
Shares Statistics:
According to the various share statistics, PATH traded on average about 11.77M shares per day over the past 3-months and 13154680 shares per day over the past 10 days. A total of 457.42M shares are outstanding, with a floating share count of 409.57M. Insiders hold about 23.45% of the company’s shares, while institutions hold 55.73% stake in the company. Shares short for PATH as of 1752537600 were 58879215 with a Short Ratio of 5.00, compared to 1749772800 on 54466517. Therefore, it implies a Short% of Shares Outstanding of 58879215 and a Short% of Float of 16.18.
Earnings Estimates
Currently, 18.0 analysts are dedicated to thoroughly evaluating and rating the performance of UiPath Inc (PATH) in the stock market.The consensus estimate for the next quarter is $0.12, with high estimates of $0.14 and low estimates of $0.07.
Analysts are recommending an EPS of between $0.61 and $0.44 for the fiscal current year, implying an average EPS of $0.55. EPS for the following year is $0.61, with 21.0 analysts recommending between $0.72 and $0.49.
Revenue Estimates
According to 15 analysts, the current quarter’s revenue is expected to be $347.36M. It ranges from a high estimate of $348.59M to a low estimate of $345M. As of the current estimate, UiPath Inc’s year-ago sales were $316.25MFor the next quarter, 15 analysts are estimating revenue of $384.3M. There is a high estimate of $390M for the next quarter, whereas the lowest estimate is $373.4M.
A total of 18 analysts have provided revenue estimates for PATH’s current fiscal year. The highest revenue estimate was $1.55B, while the lowest revenue estimate was $1.55B, resulting in an average revenue estimate of $1.55B. In the same quarter a year ago, actual revenue was $1.43BBased on 20 analysts’ estimates, the company’s revenue will be $1.68B in the next fiscal year. The high estimate is $1.75B and the low estimate is $1.64B.
